The 5 most common COVID-19 symptoms based on your vaccination status, in one chart

• COVID-19 symptoms look a bit different for vaccinated people and unvaccinated people, a study found.
• Unvaccinated people are more likely to report a fever and persistent cough.
• They're also more likely to get severely sick and reported more symptoms in total.

The Delta variant is challenging vaccines more than any other coronavirus strain: It seems to make it easier for vaccinated people to spread the virus and become infected themselves, according to data from the Centers for Disease Control and Prevention.

Vaccines still protect against severe disease - a leaked CDC presentation showed that vaccines reduced the risk of hospitalization or death by 25 times in the face of Delta. But a small minority of vaccinated people may develop a "breakthrough case" of COVID-19.

The CDC is recording about 35,000 breakthrough cases a week among 162 million vaccinated Americans, a rate of 0.02%. That data may be limited, since the CDC in May stopped tracking asymptomatic, mild, and moderate breakthrough cases at a national level.

So far, breakthrough cases are more likely to resemble a cold than our original picture of COVID-19, which focused on symptoms like fever, a dry cough, and shortness of breath.

The following chart shows the five most common COVID-19 symptoms based on your vaccination status. The data comes from the COVID Symptom Study, a project that tracks self-reported COVID-19 symptoms among more than 1 million people in the UK.

Vaccinated people have milder illnesses and faster recoveries

Studies from England and Scotland indicate that Pfizer's vaccine reduces the risk of a symptomatic Delta infection by 88%, down from 95% for the original strain. The vaccine also lowers the risk of any type of Delta infection by 79% and of hospitalization from Delta by 96%, the studies found.

So it's no surprise that the biggest difference between infections among the vaccinated and unvaccinated in the COVID Symptom Study was the severity and duration of their illnesses. Vaccinated people reported fewer symptoms, which were more fleeting, than those who were unvaccinated.

Delta appears to cause more severe illness than other variants, making vaccines all the more necessary to protect against hospitalization and death. The CDC recently estimated that unvaccinated people represented about 97% of COVID-19 hospitalizations in the US.

"Whether you've been vaccinated or not, that determines how sick you might become," Dr. Barney Graham, the deputy director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, said during a discussion last month. "But what determines how likely you are to be infected is how much infection is around you in the community."

He added that "there's more likely to be infection if you're partially immune, or there's more likely to be severe disease if you're not immune at all."

Differences in symptoms

Headaches, runny noses, and sore throats were commonly reported in the COVID Symptom Study, regardless of a person's vaccination status. But fully vaccinated people were more likely to report loss of smell, and unvaccinated people were more likely to report fevers. A persistent cough was also more common among unvaccinated people and those who'd received just one dose of a vaccine than among fully vaccinated people.

Shortness of breath was relatively uncommon overall, even among unvaccinated people. Part of the reason could be that young people - who are less likely to develop severe symptoms - represent a greater share of COVID-19 cases now than they did at the start of the pandemic. (A study from Imperial College London that hasn't been peer-reviewed found that coronavirus cases in the UK were 2.5 times more prevalent among people younger than 50 than among those 50 and up as of June.)

That said, COVID-19 symptoms can still run the gamut. A recent CDC analysis of an outbreak in Barnstable County, Massachusetts, found that a cough, a headache, a sore throat, muscle pain, and fever were common symptoms among people with breakthrough cases. Nearly 80% of breakthrough cases in that community were symptomatic.